- Home
- IPHA vs OGI Comparison
IPHA vs OGI Comparison
Compare IPHA & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- OGI
- Stock Information
- Founded
- IPHA 1999
- OGI 2013
- Country
- IPHA France
- OGI Canada
- Employees
- IPHA N/A
- OGI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- IPHA Health Care
- OGI Health Care
- Exchange
- IPHA Nasdaq
- OGI Nasdaq
- Market Cap
- IPHA 160.1M
- OGI 155.2M
- IPO Year
- IPHA 2019
- OGI N/A
- Fundamental
- Price
- IPHA $2.18
- OGI $1.34
- Analyst Decision
- IPHA Strong Buy
- OGI
- Analyst Count
- IPHA 1
- OGI 0
- Target Price
- IPHA $11.00
- OGI N/A
- AVG Volume (30 Days)
- IPHA 28.8K
- OGI 592.7K
- Earning Date
- IPHA 03-27-2025
- OGI 05-12-2025
- Dividend Yield
- IPHA N/A
- OGI N/A
- EPS Growth
- IPHA N/A
- OGI N/A
- EPS
- IPHA N/A
- OGI 0.10
- Revenue
- IPHA $20,831,349.00
- OGI $135,031,829.00
- Revenue This Year
- IPHA $209.83
- OGI $50.30
- Revenue Next Year
- IPHA $83.15
- OGI $16.01
- P/E Ratio
- IPHA N/A
- OGI $15.16
- Revenue Growth
- IPHA N/A
- OGI 20.49
- 52 Week Low
- IPHA $1.29
- OGI $0.85
- 52 Week High
- IPHA $3.51
- OGI $2.08
- Technical
- Relative Strength Index (RSI)
- IPHA 53.46
- OGI 57.02
- Support Level
- IPHA $2.06
- OGI $1.30
- Resistance Level
- IPHA $2.24
- OGI $1.38
- Average True Range (ATR)
- IPHA 0.09
- OGI 0.07
- MACD
- IPHA -0.01
- OGI -0.00
- Stochastic Oscillator
- IPHA 53.33
- OGI 55.10
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.